PROGEN — Prostatype Genomics AB Share News
0.000.00%
Last trade - 00:00- SEK27.88m
- SEK24.11m
- SEK0.59m
Brief: Anders Lundberg Is Elected Chairman Of Prostatype Genomics
Brief: Prostatype Genomics Updates On Progress With Prostatype Study
Brief: Prostatype Genomics Announces Strong Positive Final Results From Multicentre Study With Prostatype In Spain
Brief: Prostatype Genomics H2 EBITDA Loss Widens To SEK 17.8 Mln
Brief: Prostatype Genomics Gets CAP Laboratory Accreditation
Brief: Prostatype Genomics Acquires Clia Certificate
Brief: Prostatype Genomics, Researchdx In CLIA-Laboratory Agreement For US Market
Brief: Prostatype Genomics Carries Out Directed Share Issue
Brief: Prostatype Genomics Announces Preliminary Outcome Of Rights Issue
Brief: Prostatype Genomics Says Net Sales For Q3 Amounted To Approx 530 Tsek, Compared To 109 Tsek For Same Period Last Year
Brief: Prostatype Genomics Informs About Market Capitalization Value On Certain Financial Websites
Brief: Prostatype Genomics Resolves On Rights Issue Of About SEK 47.8 Mln
Brief: Prostatype Genomics Gets First Order Of Prostatype® In Switzerland
Brief: Prostatype Genomics Appoints Anders Koch As New CFO
Brief: Prostatype Genomics Says Running Costs Are Reduced By About 30% (Approx Sek 9 Million On An Annual Basis) Without Affecting Sales And Continued Research.
Brief: Prostatype Genomics Says CFO Michael Af Winklerfelt Is Leaving The Company
Brief: Prostatype Genomics - Prostatype Superior In New Study Published In The Prostate
Brief: Prostatype Expects Significantly Better Performance In Q3
Brief: Prostatype Genomics Q1 EBITDA Loss At SEK 7.3 Mln